GlassScriptPhysician profile
Noemi Brizuela
NPI 1083153845
$3,092.99
in general payments reported to CMS, 2019-2025
19 companies · $1,092 in 2025
The $1,092 reported for 2025 was more than what 86% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $78.13 · 2022: $215 · 2023: $1,172 · 2024: $536 · 2025: $1,092.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,922 · Travel and Lodging: $477 · Honoraria: $400.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,921.98 |
| Travel and Lodging | $477.48 |
| Honoraria | $400.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Relievant Medsystems, INC. | $849.31 | 2022-2023 | Intracept |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $593.03 | 2023-2025 | Relistor |
| Scilex Pharmaceuticals INC. | $486.32 | 2022-2025 | Ztlido |
| Protega Pharmaceutials INC | $467.12 | 2022-2025 | Roxybond |
| Forte Bio-Pharma LLC | $197.40 | 2021-2025 | Prolate, Nalocet, Tanlor |
| Boston Scientific Corporation | $71.34 | 2021-2025 | Intracept Rf Probe |
| Spr Therapeutics, INC | $66.00 | 2023 | Sprint Pns System |
| Vertos Medical, INC. | $55.72 | 2024 | Mild Device Kit |
| Valinor Pharma, LLC | $55.42 | 2025 | Movantik |
| Medtronic, INC. | $50.87 | 2023 | Intellis Adaptivestim |
| Vertex Pharmaceuticals Incorporated | $45.63 | 2024-2025 | |
| Ibsa Pharma INC. | $29.25 | 2023-2024 | Tirosint, Licart, Tirosint |
| Nevro Corp. | $24.55 | 2021 | |
| Hikma Pharmaceuticals USA | $21.00 | 2022 | |
| Depuy Synthes Sales INC. | $17.82 | 2023 | Orthovisc |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Averitas Pharma INC. | $16.70 | 2025 | Qutenza |
| Si-Bone, INC. | $15.94 | 2024 | |
| Abbvie INC. | $14.82 | 2022 | |
| Allergan, INC. | $14.75 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Noemi Brizuela listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.